Many thoracic oncologists used telehealth for fi rst time during pandemic

Baird and colleagues on the IASLC communications committee created a 24-ques-tion survey to assess telehealth use during the pandemic and its impact lung cancer or mesothelioma care from the viewpoint of health care professionals. When researchers examined the impact of COVID-19 on the care pathway, most respondents reported fewer presenting patients (83%), delays from transition from primary care to a hospital setting (82%), delays accessing trials (74%) and delays accessing surgery (73%). A majority also reported a reduction in the number of clinical trials (74%), a halting of current trials (62%), a decrease in research activity (69%) and a reduction in protected research time (61%).